Status:
TERMINATED
Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
Lead Sponsor:
Columbia University
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to assess how an at-home COVID-19 frequent testing regimen using the CoV-SCAN test kit and a paired phone application to help interpret the test result compares to once-a-week or three...
Detailed Description
Antigen tests are simple to perform, have a rapid turn-around time of 15-30 minutes, and a lower cost than molecular tests. Because antigen tests do not incorporate an amplification step, they are int...
Eligibility Criteria
Inclusion
- Aged 18 years or older;
- Have a smartphone;
- Understand and read English;
- Will be on one production location for at least three weeks following enrollment to the study;
- Will be willing to be contacted by the Study Coordinator after leaving one production location to facilitate continued access to weekly molecular testing;
Exclusion
- Have received any dose of COVID-19 vaccination;
- Have been diagnosed with COVID-19 infection.
Key Trial Info
Start Date :
February 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 14 2021
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT04805840
Start Date
February 19 2021
End Date
July 14 2021
Last Update
November 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032